Evidence map›Paper›PMID 27072972›Full record

ArticleJournal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban2016

Comparison of efficacy of different treatments for pulmonary embolism.

Yang Fan, He Huang, Jun Xiong, Mei Yang, Bin Kong, Jia-Fen Liao, Wang-Wei He, Zhi-Qiang Wang

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Progress in the research on venous thromboembolism.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yang FanDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
He HuangDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060, China. huanghe1977@whu.edu.cn.
Jun XiongDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Mei YangDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Bin KongDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Jia-Fen LiaoDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Wang-Wei HeDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Zhi-Qiang WangDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Renmin Hospital of Wuhan University · CNWuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An optimal therapy for pulmonary embolism (PE) was explored by comparing three different methods in order to alleviate the sufferings of PE patients and reduce the mortality. Eighty patients with PE diagnosed by computed tomography angiography (CTA) were treated with thrombolysis, anticoagulation only, or surgery/intervention. The clinical efficacy of different treatments were compared and analyzed. Twenty-four out of the 26 patients (92%) in anticoagulation only group showed improvement in CTA and clinical presentations, which was significantly higher than that in the thrombolysis group (87%, n=39, P<0.05). However, there was no significant difference in the rate of mortality between thrombolysis group and anticoagulation only group. In the surgery/interventional group (n=15), the success rate was 47%, and the mortality rate was 14%. Both of them were significantly different from those in thrombolysis and anticoagulation only groups (both P<0.05). Log-rank analysis of the data of 5-year follow-up revealed that the survival time in surgery/intervention group was significantly shorter than in the other two groups (P<0.05). It was suggested that it is of importance to choose the appropriate therapeutic regimen for PE patients. Mortality may be reduced and prognosis may be improved with anticoagulation only and thrombolysis therapy.

Indexed as

AdolescentAdultAgedAged, 80 and overAnticoagulantsFemaleHumansMaleMiddle AgedPostoperative ComplicationsPulmonary EmbolismPulmonary Surgical ProceduresSurvival AnalysisThrombolytic TherapyAnticoagulantsanticoagulationevaluation of therapeutic efficacypulmonary embolismthrombolysistreatment choice

Identifiers

PMID27072972
OpenAlexW2337215931

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.